Epilepsy Talk

Death, Depression and AEDs

March 3, 2020
23 Comments

“Suicide Risk from 11 Anti-Epilepsy Drugs,” headlines blared across the country.

But we’re still here.

Was it sensationalism by the journalists, irresponsibility by the pharmaceutical industry or laxness of the FDA?

Posted in Epilepsy, Medication Issues, Research
Tags: anti-epilepsy drugs, depakote, depression, FDA analysis, Felbatol, Gabitril, Keppra, Lamictal, Lyrica, Neurontin, suicide risk, Tegretol, Topamax, Trileptal, Zonegran

Most Recent Posts

Coronavirus (COVID-19) — How To Get Instant Care
Weird Epilepsy Triggers
Some Stress and Anxiety Solutions…
Stress and seizures…
Seniors — Alzheimer’s, Epilepsy or Seizures?
What’s Really In Your Meds?
Autoimmune Epilepsy — Cause of Previously Unexplained Seizures?
Here’s The Difference Between Coronavirus And Flu Symptoms
The Coronavirus — What Does It Mean For You?
Generics: Important Statement From The American Academy Of Neurology

Top posts

Weird Epilepsy Triggers
Coronavirus (COVID-19) -- How To Get Instant Care
Common Epilepsy Triggers
Celebrities with Epilepsy
The Four Stages of Seizures – Prodromal, Auras, Ictal and Postictal
Did you know Snow White’s “Dopey” had epilepsy?
Epilepsy Fighting Foods
Keppra -- What People Are Saying
Here's The Difference Between Coronavirus And Flu Symptoms
Sodium and Seizures

About the author

I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

View Full Profile →

Follow Epilepsy Talk via Email

Follow Epilepsy Talk on WordPress.com

Epilepsy Talk

Death, Depression and AEDs

Phylis Feiner Johnson